Intracerebroventricular dopamine for Parkinson's disease
نویسندگان
چکیده
منابع مشابه
Intracerebroventricular dopamine for Parkinson's disease
Parkinson’s disease (PD) is the second most frequent neurodegenerative disorder worldwide. The depletion of dopamine in the nigro-striatal pathway is a main pathological hallmark that requires continuous and focal restoration. Since dopamine does not cross the digestive mucosa or the blood brain barrier, its lipophilic precursor L-dopa has been employed and remains the pivotal oral medication. ...
متن کاملSynaptic vesicle glycoprotein 2C (SV2C) modulates dopamine release and is disrupted in Parkinsons disease
Amy R. Dunn, Kristen A. Stout, Minagi Ozawa, Kelly M. Lohr, Alison I. Bernstein, Yingjie Li, Minzheng Wang, Carmelo Sgobio, Namratha Sastry, Huaibin Cai, W. Michael Caudle, and Gary W. Miller* 1. Rollins School of Public Health, Emory University, Atlanta, GA 30322. 2. Center for Neurodegenerative Disease, Emory University, Atlanta, GA 30322. 3. Transgenics Section, Laboratory of Neurogenetics, ...
متن کاملStriatal Dopamine Depletion Patterns and Early Non-Motor Burden in Parkinsons Disease
BACKGROUND The mechanism underlying non-motor symptoms in Parkinson's disease has not yet been elucidated. In this study, we hypothesized that Parkinson patients with more non-motor symptoms have a different pattern of striatal dopamine depletion, particularly in areas other than the sensorimotor striatum, compared to those with fewer non-motor symptoms. METHODS We conducted a prospective sur...
متن کاملManual Therapy Choices: A General Approach to Parkinsons Disease
In treating dysfunction, it is normal for most therapists to use a variety of modalities and methods including myofascial release, muscle-energy techniques, positional-release techniques and many more. The assumption must be that different tools achieve different effects, and the ones we choose reflect our perception as to the needs of the individual and/or of the tissues involved. Sledgehammer...
متن کاملAutomatic, unsupervised classification of dyskinesia in patients with Parkinsons Disease
One of the characteristic symptoms of patients with Parkinson Disease (PD) is a rigidity of movement. These symptoms disappear after administration of Levodopa. However, the long-term use of levodopa causes involuntary movements (dyskinesia). A proper diagnosis requires an automatic, unsupervised method for the detection and classification of levodopa induced dyskinesia. The main problem, howev...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Oncotarget
سال: 2017
ISSN: 1949-2553
DOI: 10.18632/oncotarget.17596